These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 579995)

  • 1. [On the activity of cefoxitin against enterobacteriaceae and staphylococcus aureus in vitro (author's transl)].
    Krasemann C; Mohr G
    Arzneimittelforschung; 1977; 27(11):2029-31. PubMed ID: 579995
    [No Abstract]   [Full Text] [Related]  

  • 2. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
    Shah PM; Zwischenbrugger H; Stille W
    MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of cefoperazone against clinical isolates of Enterobacteriaceae, Pseudomonas and Staphylococcus.
    Olarte J
    Clin Ther; 1980; 3(Spec Issue):130-3. PubMed ID: 6446386
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro activity of cefotaxime against enterobacteriaceae. Comparison with cephalothin, cefazolin, cefamandole, cefoxitin and cefuroxime on 117 strains isolated from neutropenic patients (author's transl)].
    Tancrede C; Mariel C; Chaigneau H; Eveno J
    Nouv Presse Med; 1981 Feb; 10(8):545-7. PubMed ID: 6259589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pH upon the activity of cefoxitin.
    Tobe K; Nishino T; Hirai Y; Nakazawa S
    J Antibiot (Tokyo); 1977 Dec; 30(12):1123-6. PubMed ID: 23373
    [No Abstract]   [Full Text] [Related]  

  • 7. [An investigation of the antibacterial activity of cefoxitin against anaerobic and aerobic bacteria in vitro (author's transl)].
    Babić I; Jelić I; Stanojević D
    Lijec Vjesn; 1980; 102(7-8):414-6. PubMed ID: 7289718
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro bactericidal action of cefoperazone, cefoxitin, cefuroxime, cefazolin and cephaloridine.
    Piantieri G; Cafarelli A; Magliulo E
    G Batteriol Virol Immunol; 1981; 74(1-6):15-25. PubMed ID: 6458524
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV; Sanders CC; Sanders W
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the variations in inoculum on the cephalosporins' in vitro antibacterial activity.
    Cafarelli A; Magliulo E; Piantieri G
    G Batteriol Virol Immunol; 1981; 74(1-6):26-38. PubMed ID: 6458525
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibacterial activity of cephamandole--a new antibiotic.
    Goyal P; Bhatia R; Baveja UK; Agarwal DS
    J Commun Dis; 1982 Jun; 14(2):130-3. PubMed ID: 6818272
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro bactericidal action of cephalosporins in different concentrations of serum.
    Magliulo E; Ceccarelli G; Bianchi PP; Piantieri G; Cafarelli A
    G Batteriol Virol Immunol; 1981; 74(1-6):39-47. PubMed ID: 6458527
    [No Abstract]   [Full Text] [Related]  

  • 13. Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates.
    Garcia-Rodriguez JA
    Clin Ther; 1980; 3(Spec Issue):117-22. PubMed ID: 6248220
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro susceptibility of clinical bacterial isolates to aminoglycosides and third-generation cephalosporins.
    Charoenphol I; Leelaporn A; Pongpech P; Dhiraputra C
    J Med Assoc Thai; 1983 Aug; 66(8):470-4. PubMed ID: 6644210
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and in vitro sensitivity of Enterobacteriaceae to cefoxitin and new cephalosporins.
    Van Landuyt HW; Pyckavet M; Vuye A
    Acta Clin Belg; 1979; 34(4):202-7. PubMed ID: 525199
    [No Abstract]   [Full Text] [Related]  

  • 16. Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion test.
    Thornsberry C; Baker CN; Barry AL; Jones RN
    Clin Ther; 1980; 3(Spec Issue):39-45. PubMed ID: 6446397
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
    Berche P; Gaillard JL
    Ann Biol Clin (Paris); 1986; 44(6):624-7. PubMed ID: 3826779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Patterns of resistance of Staph aureus and gram-negative bacteria to aminoglycosides and cephalosporins].
    Ruczkowska J; Dolna I
    Wiad Lek; 1989 May; 42(9):579-83. PubMed ID: 2629327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory concentrations of cefoperazone, cefazolin, cefamandole, cephaloridine, and cefoxitin for 300 gram-negative clinical isolates.
    Trabulsi LR; Pereira da Silva Almada N; Marques LR
    Clin Ther; 1980; 3(Spec Issue):145-8. PubMed ID: 6446390
    [No Abstract]   [Full Text] [Related]  

  • 20. Antagonism of cefamandole by cefoxitin in routine disk susceptibility tests.
    Sanders CC; Sanders WE
    Am J Clin Pathol; 1980 Apr; 73(4):562-3. PubMed ID: 7369181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.